Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lymphoma. Current status and treatment].

J R Labardini-Méndez1, A A Gutiérrez, F Martínez

  • 1Instituto Nacional de Cancerología, Coyoacán, México, D.F.

Gaceta Medica De Mexico
|July 14, 2000
PubMed
Summary

Single-cell polymerase chain reaction analysis enhances understanding of lymphoma origins and neoplastic clone survival. Research needs better definitions for new lymphoma categories and clarifies transplant management for specific non-Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study.

Open veterinary journal·2015
Same author

Feline leukemia virus outbreak in the critically endangered Iberian lynx (Lynx pardinus): high-throughput sequencing of envelope variable region A and experimental transmission.

Archives of virology·2011
Same author

Mitochondrial heat shock protein participates in placental steroidogenesis.

Placenta·2011
Same author

Partial duplication of 18q including a distal critical region for Edwards Syndrome in a patient with normal phenotype and oligoasthenospermia: case report.

Cytogenetic and genome research·2011
Same author

[Vitamin D deficiency and osteoporosis in a rural population of Cordoba province, Argentina].

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2010
Same author

Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Context:

  • Advances in single-cell polymerase chain reaction (PCR) analysis offer novel insights into the origins of lymphoid neoplasms, including Hodgkin's disease and Burkitt lymphoma.
  • Research into apoptosis and neoplastic clone survival mechanisms is a rapidly expanding field within hematologic oncology.
  • The classification of lymphoid neoplasms requires updates to accommodate new entities and variants, facilitating improved understanding, learning, and teaching.

Purpose:

  • To review current understanding of lymphoid neoplasms, highlighting areas needing further definition and research.
  • To discuss the challenges in classifying new lymphoma categories like lymphoplasmacytic lymphoma, mantle cell lymphoma variants, marginal zone B-cell lymphomas, and NK-cell lymphomas.
  • To evaluate the role of transplantation in managing follicular, low-grade non-Hodgkin's lymphoma and aggressive lymphomas.

Related Experiment Videos

Summary:

  • Single-cell PCR aids in understanding lymphoma origins and neoplastic clone survival.
  • Current data present challenges in defining new lymphoma categories and determining optimal transplantation strategies for follicular lymphoma.
  • Treatment for aggressive lymphomas remains controversial, with CHOP chemotherapy as a standard, and high-dose therapy with transplantation showing potential for high-risk patients.

Impact:

  • Improved classification and definition of lymphoid neoplasms will enhance diagnostic accuracy and therapeutic strategies.
  • Clarification of transplantation protocols for specific lymphoma subtypes may optimize patient outcomes.
  • Ongoing research into molecular mechanisms and therapeutic approaches promises to advance the management of hematologic malignancies.